Objective: To probe the effects of qi-supplementing and yin-nourishing therapy (blood-increasing decoction and blood generating powder) on chronic thrombocytopenia. Methods: Two hundred patients with chronic thrombocy...Objective: To probe the effects of qi-supplementing and yin-nourishing therapy (blood-increasing decoction and blood generating powder) on chronic thrombocytopenia. Methods: Two hundred patients with chronic thrombocytopenia were randomly divided into control (n=100) and test groups (n = 100) with Amino-polypeptide as a basic treatment for both. Test group patients consumed a blood-increasing decoction and blood-generating powder for 1-3 months. Improvements in platelet counts and TCM syndrome were observed. Results: One hundred and sixty-four (80 in the test group and 84 in the control group) of 189 total participants were treated for 3 months. The total effective rate in improving TCM syndrome was 95.00% in the test group and 79.76% in the control group (P<0.05). There was significant difference (P<0.05) in the accumulated score of TCM syndrome between the two groups treated at different time points. The total effective rate of platelet counts was 86.25% in the test group and 59.52% in the control group (P<0.05). There was a significant difference in platelet counts before and after treatment in the two groups (P<0.05). There was no significant differences in platelet count between the two groups treated for 1-2 months; however, a significant difference was found between the two groups after treatment for 3 months (P<0.05). Conclusions: After a 3-month treatment of chronic thrombocytopenia patients with qi-supplementing and yin-nourishing therapy, TCM syndrome was improved and platelet counts increased with no obvious side effects, and the quality of life of the participants was enhanced with noticeable long-term curative effects.展开更多
OBJECTIVE: To evaluate the therapeutic effect of Yiqi Yangyin prescription for dilated cardiomyopathy(DCM).METHODS: Electronic databases were searched for relevant clinical randomized controlled trials of DCM treatmen...OBJECTIVE: To evaluate the therapeutic effect of Yiqi Yangyin prescription for dilated cardiomyopathy(DCM).METHODS: Electronic databases were searched for relevant clinical randomized controlled trials of DCM treatment using Yiqi Yangyin prescription(Shengmai and Zhigancao decoction). Databases searched included Pub Med, EMBASE, the Cochrane Library, China National Knowledge Infrastructure Database, Wanfang Database, China Science and Technology Journal Database, and Chinese Biological Medicine from January 1, 1985, to October 31,2015. After literature screening and data extraction according to previously determined exclusion criteria, data were analyzed using Rev Man 5.3 and Stata12.0. Study heterogeneity was evaluated using the I2 test and Cochran's Q test. Egger's test was used to detect publication bias.RESULTS: Nineteen trials involving 1024 partici-pants were included in the Meta-analysis. Of these,15 used Shengmai(treatment group: 421 cases;control group: 344 cases) and 4 used Zhigancao decoction(treatment group: 133 cases; control group:126 cases). A Meta-analysis demonstrated that the total curative effect was significantly improved by combining Shengmai with conventional treatment[relative risk(RR) = 1.32, 95% confidence intervals(CI)(1.22, 1.43), P < 0.01]. Left ventricular ejection fraction [standard mean difference(SMD) = 1.13,95% CI(0.55, 1.70), P < 0.01] and left ventricular end diastolic [SMD =-0.46, 95% CI(-0.70,-0.23), P <0.01] were also improved. Adding Zhigancao decoction achieved the same effect [total efficiency of RR = 1.34, 95% CI(1.16, 1.54), P < 0.01].CONCLUSION: Compared with conventional therapy, Yiqi Yangyin prescription can significantly improve the curative effect, increase left ventricular ejection fraction, and reduce left ventricular end diastolic. Thus, it can effectively improve heart function in patients with DCM.展开更多
基金supported by National Sci-tech support program in the 11th 5-year plan (2007BAI20B064)Zhejiang Provincial TCM Administration (2007CA026)
文摘Objective: To probe the effects of qi-supplementing and yin-nourishing therapy (blood-increasing decoction and blood generating powder) on chronic thrombocytopenia. Methods: Two hundred patients with chronic thrombocytopenia were randomly divided into control (n=100) and test groups (n = 100) with Amino-polypeptide as a basic treatment for both. Test group patients consumed a blood-increasing decoction and blood-generating powder for 1-3 months. Improvements in platelet counts and TCM syndrome were observed. Results: One hundred and sixty-four (80 in the test group and 84 in the control group) of 189 total participants were treated for 3 months. The total effective rate in improving TCM syndrome was 95.00% in the test group and 79.76% in the control group (P<0.05). There was significant difference (P<0.05) in the accumulated score of TCM syndrome between the two groups treated at different time points. The total effective rate of platelet counts was 86.25% in the test group and 59.52% in the control group (P<0.05). There was a significant difference in platelet counts before and after treatment in the two groups (P<0.05). There was no significant differences in platelet count between the two groups treated for 1-2 months; however, a significant difference was found between the two groups after treatment for 3 months (P<0.05). Conclusions: After a 3-month treatment of chronic thrombocytopenia patients with qi-supplementing and yin-nourishing therapy, TCM syndrome was improved and platelet counts increased with no obvious side effects, and the quality of life of the participants was enhanced with noticeable long-term curative effects.
基金Supported by Research Project of Wuxi Hospital Management Center(Comparative Study on the Effect of Yiqi Yangyin Prescription for Treatment of Autoimmune Myocarditis and Immunity Regulation Mechanism,No.YGZXM1526)
文摘OBJECTIVE: To evaluate the therapeutic effect of Yiqi Yangyin prescription for dilated cardiomyopathy(DCM).METHODS: Electronic databases were searched for relevant clinical randomized controlled trials of DCM treatment using Yiqi Yangyin prescription(Shengmai and Zhigancao decoction). Databases searched included Pub Med, EMBASE, the Cochrane Library, China National Knowledge Infrastructure Database, Wanfang Database, China Science and Technology Journal Database, and Chinese Biological Medicine from January 1, 1985, to October 31,2015. After literature screening and data extraction according to previously determined exclusion criteria, data were analyzed using Rev Man 5.3 and Stata12.0. Study heterogeneity was evaluated using the I2 test and Cochran's Q test. Egger's test was used to detect publication bias.RESULTS: Nineteen trials involving 1024 partici-pants were included in the Meta-analysis. Of these,15 used Shengmai(treatment group: 421 cases;control group: 344 cases) and 4 used Zhigancao decoction(treatment group: 133 cases; control group:126 cases). A Meta-analysis demonstrated that the total curative effect was significantly improved by combining Shengmai with conventional treatment[relative risk(RR) = 1.32, 95% confidence intervals(CI)(1.22, 1.43), P < 0.01]. Left ventricular ejection fraction [standard mean difference(SMD) = 1.13,95% CI(0.55, 1.70), P < 0.01] and left ventricular end diastolic [SMD =-0.46, 95% CI(-0.70,-0.23), P <0.01] were also improved. Adding Zhigancao decoction achieved the same effect [total efficiency of RR = 1.34, 95% CI(1.16, 1.54), P < 0.01].CONCLUSION: Compared with conventional therapy, Yiqi Yangyin prescription can significantly improve the curative effect, increase left ventricular ejection fraction, and reduce left ventricular end diastolic. Thus, it can effectively improve heart function in patients with DCM.